the aid library

Filter

14830

Evolution and effectiveness of bilateral and multilateral development assistance for health: a mixed-methods review of trends and strategic shifts (1990–2022)

Xie S., Du S., Huang Y., et al. BMJ Global Health (2025) CC

Development assistance for health (DAH) plays a vital role in supporting health programmes in lowand middle-income countries. While DAH has historically focused on infectious diseases and maternal and child health, there is a lack of comprehensive analysis of DAH trends, strategic shifts and the ... more

External Link

Perceptions of healthcare finance and system quality among Nigerian healthcare workers

Josiah B.O., Enebeli E.C., Duncan B.A., et al. PLOS Global Public Health (2024) CC

Nigeria’s healthcare system faces significant challenges in financing and quality, impacting the delivery of services to its growing population. This study investigates healthcare workers’ perceptions of these challenges and their implications for healthcare policy and practice. A cross-sectiona ... more

External Link

How feasible is it to mobilize $31 billion a year for pandemic preparedness and response? An economic growth modelling analysis

Shahid M., Schäferhoff M., Brown G., et al. Globalization and Health (2024) CC

Covid-19 has reinforced health and economic cases for investing in pandemic preparedness and response (PPR). The World Bank and World Health Organization (WHO) propose that low- and middle-income governments and donor countries should invest $31.1 billion each year for PPR. We analyse, based on the ... more

Download

View PDF

Conditioned Domestic “Co-financing” Policies in Global Health

Sparkes S., Yungrattanachai M., Fan V., et al. Center for Global Development (2024) CC

Conditioned domestic financing policy, referring to the domestic financing of health projects, programs, and national responses conditioned by global health funding agencies and recipient country governments, is one mechanism to promote sustainability and country ownership. We aim to understand how ... more

External Link

Financing for equity for women’s, children’s and adolescents’ health in low- and middleincome countries: A scoping review

Bou-Karroum L., Iaia D.G. , El-Jardali F., et al. PLOS Global Public Health (2024) CC

Over the past few decades, the world has witnessed considerable progress in women’s, children’s and adolescents’ health (WCAH) and the Sustainable Development Goals (SDGs). Yet deep inequities remain between and within countries. This scoping review aims to map financing interventions and meas ... more

External Link

Financialisation: a 21st century commercial determinant of health equity

Friel S., Schram A., Frank N., et al. Lancet Public Health (2024) CC

In 21st century capitalism, financial markets reign supreme. The elevation of investing, trading, and speculating as a way of making profit has shifted economic power towards institutional investors and enhanced the power of financial capital. Financialisation has introduced uncertainty in the commi ... more

Download

View PDF

Financing the Pandemic Cycle: Prevention, Preparedness, Response, and Recovery and Reconstruction

Fan V. Y., Kim S., Pineda D., et al. Center for Global Development (2024) CC

The COVID-19 pandemic exposed critical gaps in the global response to health crises, particularly in the financing of pandemic prevention, preparedness, response, recovery, and reconstruction. This chapter presents a comprehensive framework for pandemic financing that spans the entire pandemic cycle ... more

External Link

Financing pandemic prevention, preparedness and response: lessons learned and perspectives for future

Ndembi N., Dereje N., Nonvignon J., et al. Globalization and Health (2024) CC

The attainment of global health security goals and universal health coverage will remain a mirage unless African health systems are adequately funded to improve resilience to public health emergencies. The COVID-19 pandemic exposed the global inequity in accessing medical countermeasures, leaving Af ... more

External Link

Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17

Dingle, A.; Schäferhoff, M.; Borghi, J. et al. The Lancet (2020) CC

Background Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul ... d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017. Methods Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators. Findings After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million). Interpretation Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention. Funding Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health. more

External Link

National spending on health by source for 184 countries between 2013 and 2040

Dieleman, J.; Templin, T.; Sadat, N. et al. (2016) CC

A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at simi ... lar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected. Methods We extracted data from WHO's Health Spending Observatory and the Institute for Health Metrics and Evaluation's Financing Global Health 2015 report. We converted these data to a common purchasing power-adjusted and inflation-adjusted currency. We used a series of ensemble models and observed empirical norms to estimate future government out-of-pocket private prepaid health spending and development assistance for health. We aggregated each country's estimates to generate total health spending from 2013 to 2040 for 184 countries. We compared these estimates with each other and internationally recognised benchmarks. Findings Global spending on health is expected to increase from US$7·83 trillion in 2013 to $18·28 (uncertainty interval 14·42–22·24) trillion in 2040 (in 2010 purchasing power parity-adjusted dollars). We expect per-capita health spending to increase annually by 2·7% (1·9–3·4) in high-income countries, 3·4% (2·4–4·2) in upper-middle-income countries, 3·0% (2·3–3·6) in lower-middle-income countries, and 2·4% (1·6–3·1) in low-income countries. Given the gaps in current health spending, these rates provide no evidence of increasing parity in health spending. In 1995 and 2015, low-income countries spent $0·03 for every dollar spent in high-income countries, even after adjusting for purchasing power, and the same is projected for 2040. Most importantly, health spending in many low-income countries is expected to remain low. Estimates suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income countries will reach the Chatham House goal of 5% of gross domestic product consisting of government health spending. Interpretation Despite remarkable health gains, past health financing trends and relationships suggest that many low-income and lower-middle-income countries will not meet internationally set health spending targets and that spending gaps between low-income and high-income countries are unlikely to narrow unless substantive policy interventions occur. Although gains in health system efficiency can be used to make progress, current trends suggest that meaningful increases in health system resources will require concerted action. Funding Bill & Melinda Gates Foundation. more

Download

View PDF

Theory of Change

Nutrition and Food Security Alliance of Namibia; UNFPA; UNICEF; et al. (2020) CC2

Early Identification and Early Intervention Services for Young Children with Developmental Delays and Disabilities in Namibia Republic of Namibia Namibia Regional Consultations Report

Download

View PDF

Tracking AMR Country Self Assessment Survey (TrACSS) 2022 Country Report Namibia

Food and Agriculture Organization of the United Nations FAO; UN environment programme; World Health Organization WHO; et al. (2022) C_WHO

Fact sheet

External Link

Malaria “chemoprevention and vaccination strategies” for children living in endemic areas of Africa: a review

Nambatya, W.; M. Ocan, B. Robberstad , et al. (2025) CC

Front. Malar. 3:1336324. doi: 10.3389/fmala.2025.1336324

Download

View PDF

Communiation Interpersonnelle pour la Vaccination: Cartes de Référence

UNICEF; Bill & Melinda Gates Foundation; CDC; et al. (2022) C_UNICEF

Les cartes de référence sur la communication interpersonnelle pour la vaccination ont été créées pour faciliter l’accès à l’information sur les vaccins et les maladies évitables par la vaccination. Ces cartes peuvent servir d’outi ... more

External Link

Antimalarial drugs for treating and preventing malaria in pregnant and lactating women

Saito, M.; Gilder, M. E.; McGready, R. et al. (2018) C2

EXPERT OPINION ON DRUG SAFETY 2018, VOL. 17, NO. 11, 1129–1144. Malaria during and after pregnancy contributes significantly to maternal mortality and adverse fetal outcomes. While effective and safe antimalarial treatments are essential, quinine — an older, less effective drug — has long bee ... more

External Link

Empfehlungen zur Malariaprophylaxe

Rothe, C.; O. Veit, D. Rosenbusch, et al. Georg Thieme Verlag KG (2024) CC2

Flugmedizin · Tropenmedizin · Reisemedizin - FTR 2024; 31(04): 165-206 DOI: 10.1055/a-2351-8414

External Link

Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses

Cohee, LM.; C. Opondo, S. E Clarke, et al. (2020) C1

Lancet Glob Health 2020 Published Online October 22, 2020 https://doi.org/10.1016/S2214-109X(20)30325-9

External Link

Identification and management of co-infections in people with malaria

Cunnington, A.; A. Abbara, F. Kaduni Bawa, et al. (2024) CC2

BMJ 2024 Mar 13:384:e077512. doi: 10.1136/bmj-2023-077512. Co-infections in individuals with malaria are common, particularly in endemic areas, and can significantly impact disease severity and outcomes. Effective management requires prompt diagnosis of both malaria and any co-occurring infections, ... more

External Link

HIV-1 Impact on Malaria Transmission: A Complex and Relevant Global Health Concern

Roberds, A.; E. Ferraro, S. Luckhart, et al. (2021) CC2

Front. Cell. Infect. Microbiol., 12 April 2021 Sec. Parasite and Host Volume 11 - 2021 | https://doi.org/10.3389/fcimb.2021.656938 Over the past several decades, malaria/HIV-1 co-infection has become a significant global public health problem in co-endemic areas of the world.

External Link

The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region

Unger, H.W.; S. Acharya, L. Arnold, et al (2023) C1

Lancet Glob Health 2023; 11: e1805–18